{"id":"W2166010840","doi":"10.1111/j.1464-410x.2011.10629.x","title":"Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials","year":2011,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":267,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Temsirolimus; Pazopanib; Medicine; Sunitinib; Axitinib; Oncology; Internal medicine; Bevacizumab; Sorafenib; Everolimus; Clinical trial; Renal cell carcinoma; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Chemotherapy; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02281006,0.003012153,0.02102793,0.01295426,0.0009161479,0.003744225,0.003333203,0.00355499,0.009100698],"category_scores_gemma":[0.0768943,0.001902187,0.0129243,0.01148859,0.001518537,0.004082541,0.002232444,0.002406956,0.0005937602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008009069,"about_ca_system_score_gemma":0.01170197,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008478085,"about_ca_topic_score_gemma":0.0177431,"domain_scores_codex":[0.9733685,0.01364857,0.007747295,0.001449388,0.003265466,0.0005208704],"domain_scores_gemma":[0.9535868,0.03175248,0.01044807,0.0006176753,0.003032893,0.0005619627],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000997024,0.00001569442,0.0002143465,0.9656713,0.01859632,0.00004907851,0.00007986052,0.0001306108,0.00008618938,0.0001735929,0.00072952,0.01325639],"study_design_scores_gemma":[0.005265217,0.0006121447,0.002166944,0.7937446,0.1855512,0.0002481366,0.0002342252,0.00025611,0.0001980247,0.0007501974,0.010904,0.00006922641],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001470963,0.99518,0.0003791643,0.0003182092,0.0001967656,0.001661231,0.0004241921,0.00002500163,0.0003444395],"genre_scores_gemma":[0.03061216,0.9590441,0.002696187,0.001078271,0.0001608179,0.005676777,0.0004067621,0.00002421079,0.0003007479],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02281006,"threshold_uncertainty_score":0.1206325,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05609752772833089,"score_gpt":0.3551985738165855,"score_spread":0.2991010460882547,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}